M. OʼReilly

7.4k citations
30 papers · 6.0k · 3 hit papers · h-index 14

Impact in

Papers in

    • Lung Cancer Research Studies 5
    • Cancer-related Molecular Pathways 3
    • Pancreatic and Hepatic Oncology Research 3
    • Angiogenesis and VEGF in Cancer 9

M. OʼReilly

29 papers receiving 5.9k citations

M. OʼReilly's Hit Papers

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. 2000 · 1.3k citations
1.3k0+10+21Years since publication50010001.5k2.0k2.5k

Peers

M. OʼReilly
Comparison fields: 5 of 118
  • Cancer Research 2.0k
  • Immunology and Allergy 622
  • Oncology 1.6k
  • Molecular Biology 3.4k
  • Biotechnology 325
Replace Julio A. Aguirre‐Ghiso with:
Julio A. Aguirre‐Ghiso United States
Jasti S. Rao United States
Sachie Hiratsuka Japan
Oriol Casanovas Spain
Yuval Shaked Israel
Anna C. Obenauf Austria
Pnina Brodt Canada
Sonja Loges Germany
David R. Shalinsky United States
Joseph P. Semple United States
M. OʼReilly relative to Julio A. Aguirre‐Ghiso United States Julio A. Aguirre‐Ghiso's profile →
Citations per field
00.5×1.5×
Julio A. Aguirre‐Ghiso · 1×
Citations per year

Countries citing papers authored by M. OʼReilly

Since Specialization
Citations

This map shows the geographic impact of M. OʼReilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. OʼReilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. OʼReilly more than expected).

Fields of papers citing papers by M. OʼReilly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. OʼReilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. OʼReilly. The network helps show where M. OʼReilly may publish in the future.

Co-authors

The 25 scholars most cited alongside M. OʼReilly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. OʼReilly Line = papers co-authored together M. OʼReilly links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
Hit paper breakdown →
19942716
2
Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.
Hit paper breakdown →
20001277
3
Inhibition of Angiogenesis In Vivo by Interleukin 12
Hit paper breakdown →
1995616
4 1996271
5 1995247
6 1998207
7 1994172
8 2013166
9 2002138
10
Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth.
199786
11 200550
12 200835
13 200514
14 201113
15 20037
16 20043
17 20163
18 20142
19 20232
20 20042

About M. OʼReilly

M. OʼReilly is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 30 papers that have together received 6.0k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (9 papers), Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Research Studies (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Cancer-related Molecular Pathways (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Advanced Radiotherapy Techniques (2 papers). The work is most often cited by research in Cancer Research (2.0k citations), Immunology and Allergy (622 citations), Oncology (1.6k citations), Molecular Biology (3.4k citations) and Biotechnology (325 citations). M. OʼReilly has collaborated with scholars based in United States, China and Sweden. Frequent co-authors include Judah Folkman, J Folkman, Birgit M. Kräling, Catherine Butterfield, Bin Shi, Blair Marshall, Gary A. Truitt, Emile E. Voest, Robert J. D’Amato and Lars Holmgren. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Radiotherapy and Oncology, Clinical Cancer Research and ESMO Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact